CAFC Affirms Preliminary Injunction Against RaDaR Cancer Assay in Precedential Decision

“The CAFC found that NeoGenomics was incorrect in arguing that the mere vulnerability of the patent’s validity defeated injunctive relief.” On July 12, the U.S. Court of Appeals for the Federal Circuit issued a precedential opinion in Natera, Inc. v.…








